A Promising New Approach For Glaucoma
Recent medical breakthroughs in RGC (retinal ganglion cell) replacement therapy offer hope for those suffering from glaucoma. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 18, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Know the Facts About Glaucoma
TUESDAY, Jan. 2, 2024 -- Glaucoma can steal your sight before you even realize it, and early diagnosis is the best way to prevent it.Many of the 3 million Americans who have glaucoma are unaware of it because they have no symptoms, according to the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 2, 2024 Category: General Medicine Source Type: news
Trio of Eye Diseases Linked to Falls, Fractures in Older Adults
(MedPage Today) -- Older adults with cataracts, age-related macular degeneration (AMD), and glaucoma are all more likely to have falls or fractures compared with those without these eye diseases, a population-based cohort study suggested.
While... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 1, 2024 Category: Primary Care Source Type: news
Risk of falls and fractures in individuals with cataract, age-related macular degeneration, or glaucoma - Tsang JY, Wright A, Carr MJ, Dickinson C, Harper RA, Kontopantelis E, van Staa T, Munford L, Blakeman T, Ashcroft DM.
IMPORTANCE: Three leading disease causes of age-related visual loss are cataract, age-related macular degeneration (AMD), and glaucoma. Although all 3 eye diseases have been implicated with falls and fracture risk, evidence is mixed, with the contribution ... (Source: SafetyLit)
Source: SafetyLit - January 1, 2024 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Poor Vision & Falls: A Deadly Combo for Seniors
FRIDAY, Dec. 29, 2023 -- Seniors with vision issues are at much higher risk for dangerous falls, new research confirms.Compared to seniors with good vision, the odds for a fall rose by 38% for seniors with glaucoma, 36% for those with cataracts and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 29, 2023 Category: General Medicine Source Type: news
Prevent Blindness Joins National Glaucoma Awareness Month in January to Educate the Public and Professionals on the "Silent Thief of Sight"
Prevent Blindness provides free glaucoma educational resources, including a new promotional toolkit for "The Glaucoma Community," glaucoma patient testimonial, and medical expert interview videos CHICAGO, Dec. 27, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 27, 2023 Category: Pharmaceuticals Tags: NPT CSR Source Type: news
FDA Approves Groundbreaking iDose ® TR for Glaucoma Treatment Following Successful Clinical Trials Conducted by Parkhurst NuVision and Glaukos
Parkhurst NuVision, a leading ophthalmic clinic and Glaukos have reached a significant milestone with the U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for iDose® TR (travoprost intracameral implant) 75 mcg. This pioneering prostaglandin analog... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 19, 2023 Category: Pharmaceuticals Tags: TRI FDA Source Type: news
Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to Reach USD 9.1 billion by 2031
Wilmington, Delaware, United States, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The glaucoma treatment market was valued at US$ 6.3 billion in 2022. A CAGR of 4.3% is projected from 2023 to 2031, reaching . Research is being done on several glaucoma treatments, and…#wilmington #delaware #marketresearchinc #nationaleyeinstitute #israeli #belkinlaser #iop #oag #based #aging (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2023 Category: Consumer Health News Source Type: news
The 'Before and After': An Eye Surgeon's Unexpected Finding
(MedPage Today) -- In medicine, the sickest patients always seem to come on Friday afternoons. At the end of the week, I'm hoping to move quickly through my last few patients -- a small corneal abrasion, a routine follow-up, or a stable glaucoma... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 16, 2023 Category: American Health Source Type: news
FDA Approves Implant for Glaucoma FDA Approves Implant for Glaucoma
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 15, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
FDA Approves iDose TR (travoprost intracameral implant) for the Treatment of Glaucoma
ALISO VIEJO, Calif.--(BUSINESS WIRE) December 14, 2023 -- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2023 Category: Drugs & Pharmacology Source Type: news
Implant for Ocular Hypertension, Glaucoma Gets FDA Green Light
(MedPage Today) -- The FDA approved the travoprost intracameral implant (iDose TR) for treatment of ocular hypertension and glaucoma, device developer Glaukos announced on Thursday.
The implant is designed to provide long-duration treatment for... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 14, 2023 Category: American Health Source Type: news
Endpoints for Neuroprotection in Glaucoma Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn designs and endpoints for new glaucoma therapies that help better measure therapeutic impact and even demonstrate intraocular pressure (IOP)-independent neuroprotection. Attendees will learn about sample selection to optimize the chance of success. The featured... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 22, 2023 Category: Pharmaceuticals Source Type: news
Toku ’s AI platform predicts heart conditions by scanning inside your eye
Ehsan Vaghefi, CEO and co-founder of Toku, grew up with a blind father who lost eyesight at the age of four due to congenital glaucoma. As a result of this, his dad was involved with the Blind Foundation in his home country of Iran. Vaghefi says most of his childhood friends were either blind or…#ehsanvaghefi #toku #blindfoundation #iran #vahefi #optometry #visionscience #universityofauckland #nationalvision #topconhealthcare (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2023 Category: Consumer Health News Source Type: news
From Data To Diagnosis: A Deep Learning Approach To Glaucoma Detection
Glaucoma is a leading cause of irreversible blindness and disability worldwide. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 14, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
